March 26, 1999
News Release 99-037
Invs. Nos. 731-TA-814(P)

ITC VOTES TO CONTINUE CASE
ON CREATINE MONOHYDRATE FROM THE PEOPLE'S REPUBLIC OF CHINA

The United States International Trade Commission (ITC) today made an affirmative determination in its preliminary phase antidumping investigation involving creatine monohydrate from the People's Republic of China.

The affirmative determination means that the ITC found that there is a reasonable indication that a U.S. industry is materially injured or threatened with material injury by reason of imports of creatine monohydrate from the People's Republic of China that are allegedly sold in the United States at less than fair value.

The affirmative determination resulted from a 6-0 vote. Chairman Lynn M. Bragg, Vice Chairman Marcia E. Miller, and Commissioners Carol T. Crawford, Jennifer A. Hillman, Stephen Koplan, and Thelma J. Askey voted in the affirmative.

As a result of the ITC's affirmative determination, the U.S. Department of Commerce will continue to conduct an antidumping investigation of imports of creatine monohydrate from the People's Republic of China, with its preliminary antidumping determination due on or about July 22, 1999.

The Commission's public report Creatine Monohydrate from the People's Republic of China (Investigation No. 731-TA-814 (Preliminary)), USITC Publication 3177, April 1999) will contain the views of the Commission and information developed during the investigations.

Copies of the report are expected to be available after April 26, 1999, by calling 202-205-1809 or from the Office of the Secretary, 500 E Street SW, Washington, DC 20436. Requests may also be faxed to 202-205-2104.


UNITED STATES INTERNATIONAL TRADE COMMISSION
Office of Industries
Washington, DC 20436

FACTUAL HIGHLIGHTS

Creatine Monohydrate from China
Investigation No. 731-TA-814 (Preliminary)

Product Description: For purposes of this investigation, the product covered is commonly referred to as creatine monohydrate or creatine. Creatine is a white, tasteless, odorless powder that is a naturally occurring metabolite found in muscle tissue. It is used primarily as a nutritional and dietary supplement and to formulate some specialty weight-gain products. It is used to a comparatively minor extent in laboratory research. The merchandise subject to this investigation is provided for in subheading 2925.20.90 of the Harmonized Tariff Schedule of the United States.

Status of Proceedings:
1.      Type of investigation:  Preliminary antidumping.
2.      Petitioner: Pfanstiehl Laboratories, Inc. (Pfanstiehl).
3.      Investigation instituted by USITC: February 12, 1999.
4.      Conference: March 8, 1999.
5.      USITC vote: March 26, 1999.
6.      USITC notification of Department of Commerce: March 29, 1999.


U.S. Industry:
1.      Number of U.S. firms in 1998: Seven.
2.      Production: (1)
3.      Employment of production and related workers: (1)
4.      U.S. producers' shipments in 1998: (1)
5.      U.S. apparent consumption in 1998: (1)
6.      Ratio of quantity of total imports to U.S. apparent consumption in 1998: (1)


U.S. Imports:
1.      Quantity of subject imports in 1998: (1)  
2.      Value of subject imports in 1998:  (1)
(1) Withheld to avoid disclosure of confidential business information.

-- 30 --